Share on Pinterest Researchers have compared the effectiveness of weight loss medications such as tirzepatide and semaglutide. Jaap Arriens/NurPhoto via Getty Images Tirzepatide and semaglutide are ...
New research to be presented at this year’s European Congress on Obesity (ECO 2025, Malaga, Spain, 11-14 May) shows that around two thirds of participants of the SURMOUNT-1 trial had only regained 5% ...
Researchers from Truveta, a health data analytics company, analyzed electronic health records for more than 18,000 adults, all of whom had overweight or obesity, who were using these medications in ...
Eli Lilly and Company, along with partner institutions in the US and United Kingdom, describe how short-term pharmacologic intervention does not appear to have lasting effects for most tirzepatide ...
A winner has emerged in the ongoing battle of the bulge: Mounjaro. Overweight or obese adults are three times more likely to shed 15% of their body weight on Mounjaro than Ozempic, according to a ...
A new head-to-head study of tirzepatide versus semaglutide for weight loss in people living with obesity, but not diabetes, shows that over 72 weeks tirzepatide results in an average weight loss of 20 ...
Results from a recent study suggest that tirzepatide may be more effective in helping people who have obesity or overweight lose weight than semaglutide. People interested in using medications for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback